MedPath

Dexmedetomidine and Delirium in Elderly Patients

Not Applicable
Conditions
Delirium, Dexmedetomidine, Postoperative PCA
Interventions
Drug: Dexmedetomidine
Drug: Fentanyl-based PCA infusion
Registration Number
NCT03938831
Lead Sponsor
Korea University Guro Hospital
Brief Summary

Investigators investigates the effect of perioperative dexmedetomidine 0.5 ug/kg/hr followed by a postoperative continuous infusion fentanyl-based PCA(Patient-Controlled Analgesia) drug mixed with dexmedetomidine 0.2ug/kg/hr for two days on reducing postoperative delirium and postoperative rescue analgesics in elderly patients who undergo hip surgery. The other half of patients received fentanyl-based PCA only.

Detailed Description

Elderly patients are susceptible to postoperative delirium. Delirium occurs in 10\~60% and is associated with longer hospital stays, increased costs, and morbidity. Postoperative delirium usually occurs 2\~3 days after surgery. Intraoperative infusion of dexmedetomidine lacks preventing postoperative delirium in elderly noncardiac major surgery.

We hypothesized postoperative dexmedetomidine for two days as a mixture drug of fentanyl-based PCA could reduce the incidence of postoperative delirium. We compared this effect with other control group who received fentanyl-based PCA only.

We also investigate EEG patterns of patients during emergence and compared the EEG patterns who developed delirium postoperatively in PACU(Postanesthesia care unit) or general ward. Dexmedetomidine has analgesic effect. We expected postoperative dexmedetomidine has benefits of opioid sparing effects.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
60
Inclusion Criteria

over 65 yrs old elderly patient who undergo elective hip surgery and ASA(The American Society of Anesthesiologists) physical status I-III

Read More
Exclusion Criteria

history of dementia, drug abuser, hypersensitivity to dexmedetomidine, fentanyl, propofol, disable to speech, reject the clinical study, hemodynamic instability during surgery, an illiterate, pregnancy

Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
dexmedetomidine groupFentanyl-based PCA infusiondexmedetomidine mixture with fentanyl-based PCA infusion for 2 days
control groupFentanyl-based PCA infusionFentanyl-based PCA infusion for 2 days
dexmedetomidine groupDexmedetomidinedexmedetomidine mixture with fentanyl-based PCA infusion for 2 days
Primary Outcome Measures
NameTimeMethod
delirium2 days

reduction of incidence of delirium

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

KoreaUniversity Guro Hospital

🇰🇷

Seoul, Guro-ku, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath